GO:0030379 neurotensin receptor activity, non-G protein-coupled: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030379 describes a molecular function in which a receptor binds neurotensin and transmits a signal across the membrane without coupling to G proteins.
• Neurotensin is a neuropeptide active in the central and peripheral nervous systems of mammals, and its receptors include NTS1, NTS2 and NTS3/sortilin.
• The non-G protein-coupled activity is distinct from the classical G protein-coupled neurotensin receptor NTS1 and is associated with NTS2 and NTS3/sortilin signaling.
• NTS2 and NTS3 receptors have functional roles in pain modulation, neuroprotection, and cancer biology, making them important research targets.
• Heterodimerization of the kappa opioid receptor with neurotensin receptor 1 can produce a beta-arrestin-2-biased pathway, showing that neurotensin receptor signaling can be independent of G proteins.
• Studying GO:0030379 requires methods that separate G protein-dependent from G protein-independent signaling, such as beta-arrestin recruitment assays and knockout cell models.
Description
GO:0030379, neurotensin receptor activity, non-G protein-coupled, is a molecular function term that defines the ability of a receptor to bind neurotensin and transmit a signal across a membrane without coupling to G proteins. Neurotensin is a neuropeptide active in the central and peripheral nervous systems in mammals, and its actions are mediated by multiple receptor subtypes, including NTS1, NTS2 and NTS3/sortilin. This term is important because it distinguishes non-G protein-coupled neurotensin signaling from the classical G protein-coupled pathways that are often studied for neurotensin receptors. Researchers investigating neurotensin biology need to understand this term to correctly interpret experiments that measure beta-arrestin recruitment, receptor internalization, or G protein-independent signaling events. The kappa opioid receptor and neurotensin receptor 1 heterodimerization study provides direct evidence that neurotensin receptor 1 can contribute to a beta-arrestin-2-biased pathway, which is a G protein-independent mechanism. Therefore, GO:0030379 provides a precise annotation for gene products that mediate neurotensin responses through non-G protein-coupled mechanisms.
neurotensin receptor activity, non-G protein-coupled At A Glance
| GO ID | GO:0030379 |
|---|---|
| GO term | neurotensin receptor activity, non-G protein-coupled |
| Ontology | molecular_function |
| Synonym | neurotensin receptor activity, non G protein coupled; neurotensin receptor activity, non-G-protein coupled; non G protein coupled neurotensin receptor activity; non-G-protein coupled neurotensin receptor activity; non-G-protein-coupled neurotensin receptor activity |
| Major function | Binding neurotensin and transmitting a signal across the membrane without coupling to G proteins |
| Ligand | Neurotensin, a neuropeptide active in the central and peripheral nervous system in mammals |
| Associated receptors | NTS2 and NTS3/sortilin, and neurotensin receptor 1 in beta-arrestin-2-biased complexes |
| Signaling mode | G protein-independent, often involving beta-arrestin recruitment or other non-G protein transducers |
| Research relevance | Pain, neuroprotection, cancer, and biased signaling studies |
What Is GO:0030379?
In simple terms, GO:0030379 means a receptor binds neurotensin and passes the signal across the cell membrane without using G proteins as the signal transducer. The official definition states: Combining with neurotensin, a neuropeptide active in the central and peripheral nervous system in mammals, and transmitting the signal from one side of the membrane to the other by a mechanism independent of coupling to G proteins. This function is distinct from G protein-coupled neurotensin receptor activity and is associated with receptors such as NTS2 and NTS3/sortilin, which have functional roles in the nervous system and in cancer. The term also covers signaling events where neurotensin receptor 1 participates in beta-arrestin-2-biased pathways, as shown by heterodimerization with the kappa opioid receptor.
Why Is neurotensin receptor activity, non-G protein-coupled Important in Cell Biology?
GO:0030379 is important because it provides a precise way to annotate and study neurotensin signaling events that do not depend on G proteins. Neurotensin receptors such as NTS2 and NTS3/sortilin have functional roles in the central and peripheral nervous systems, and their non-G protein-coupled activities can influence pain, neuroprotection, and cancer progression. In addition, neurotensin receptor 1 can participate in a beta-arrestin-2-biased pathway when heterodimerized with the kappa opioid receptor, demonstrating that G protein-independent neurotensin signaling is physiologically relevant. Understanding this term helps researchers design experiments that distinguish between G protein-dependent and G protein-independent effects, which is critical for drug discovery and for interpreting knockout or knockdown phenotypes.
• Defines a specific molecular function that separates non-G protein-coupled neurotensin signaling from classical G protein-coupled pathways.
• Neurotensin is active in both the central and peripheral nervous systems, so this term is relevant to neural and endocrine research.
• NTS2 and NTS3/sortilin have functional roles in pain modulation and neuroprotection, which are linked to non-G protein-coupled activities.
• Neurotensin receptors are implicated in cancer biology, making this term relevant to oncology research.
• Heterodimerization of the kappa opioid receptor with neurotensin receptor 1 produces a beta-arrestin-2-biased pathway, a clear example of G protein-independent signaling.
• Biased signaling at neurotensin receptors is a growing area in pharmacology, and GO:0030379 provides the vocabulary for it.
• Knockout and knock-in models of neurotensin receptors can help assign specific functions to non-G protein-coupled activity.
• Assays for beta-arrestin recruitment are essential to study this term experimentally.
• Understanding this term can guide the development of drugs that selectively target G protein-independent neurotensin effects.
• It supports accurate annotation of gene products in databases and improves reproducibility across studies.
Molecular Mechanism of neurotensin receptor activity, non-G protein-coupled
Neurotensin binding and receptor activation
In simple terms: Neurotensin binds to the receptor, which changes the receptor shape and starts a signal.
The first step in GO:0030379 is the binding of neurotensin, a neuropeptide active in the central and peripheral nervous systems in mammals, to a receptor that can transmit a signal without coupling to G proteins. This binding event is the defining ligand-receptor interaction for the term, and it is shared with other neurotensin receptor activities, but the downstream mechanism is what makes this term distinct.
G protein-independent signal transmission
In simple terms: Instead of using G proteins, the receptor passes the signal through other proteins inside the cell.
After neurotensin binding, the receptor transmits the signal from one side of the membrane to the other by a mechanism independent of coupling to G proteins. This can involve beta-arrestin recruitment or other non-G protein transducers, as demonstrated by the kappa opioid receptor and neurotensin receptor 1 heterodimer, which contributes to a beta-arrestin-2-biased pathway. This step is the core of GO:0030379 and distinguishes it from classical G protein-coupled neurotensin receptor activity.
Receptor subtypes and complexes
In simple terms: Different neurotensin receptors, such as NTS2 and NTS3, can carry out this non-G protein-coupled activity.
NTS2 and NTS3/sortilin are neurotensin receptors with functional roles that include non-G protein-coupled signaling. In addition, neurotensin receptor 1 can form heterodimers with the kappa opioid receptor, and this complex produces a beta-arrestin-2-biased pathway, which is a G protein-independent mechanism. These receptor subtypes and complexes expand the range of biological contexts in which GO:0030379 is relevant.
Downstream cellular responses
In simple terms: The non-G protein signal leads to specific cell responses, such as changes in pain signaling or cell growth.
The functional consequences of non-G protein-coupled neurotensin receptor activity include roles in pain modulation, neuroprotection, and cancer biology, as described for NTS2 and NTS3 receptors. The beta-arrestin-2-biased pathway downstream of the kappa opioid receptor and neurotensin receptor 1 heterodimer represents a specific cellular response that can be measured experimentally. These responses are the physiological output of GO:0030379 and are important for understanding disease mechanisms.
Regulation and crosstalk
In simple terms: Other receptors and proteins can change how this non-G protein signal works.
Heterodimerization with the kappa opioid receptor changes neurotensin receptor 1 signaling toward a beta-arrestin-2-biased pathway, showing that receptor-receptor interactions regulate this activity. The functional roles of NTS2 and NTS3 receptors also indicate that their non-G protein-coupled activities are integrated with other signaling systems in the nervous system. Thus, regulation of GO:0030379 can occur at the level of receptor complexes and interacting proteins.
Key Genes Involved in GO:0030379 neurotensin receptor activity, non-G protein-coupled
The following genes and proteins are directly implicated in neurotensin receptor activity, non-G protein-coupled, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NTS | Encodes neurotensin, the neuropeptide ligand active in the central and peripheral nervous systems | Ligand for all neurotensin receptor activities, including GO:0030379 |
| NTSR1 | Encodes neurotensin receptor 1, which can participate in beta-arrestin-2-biased pathways | Heterodimerizes with kappa opioid receptor to produce G protein-independent signaling |
| NTSR2 | Encodes neurotensin receptor 2, a receptor with functional roles in pain and neuroprotection | Associated with non-G protein-coupled neurotensin activity |
| SORT1 | Encodes sortilin, also known as NTS3, a neurotensin receptor with functional roles | Mediates non-G protein-coupled neurotensin effects |
| OPRK1 | Encodes the kappa opioid receptor, which heterodimerizes with neurotensin receptor 1 | Forms a complex that signals through beta-arrestin-2, a G protein-independent pathway |
| ARRB2 | Encodes beta-arrestin-2, a transducer in G protein-independent signaling | Key effector for the kappa opioid receptor and neurotensin receptor 1 heterodimer |
| GNAI1 | Encodes a G protein subunit that is not used in GO:0030379 | Useful as a negative control when studying G protein-independent signaling |
| GNAQ | Encodes a G protein subunit that is not used in GO:0030379 | Helps distinguish G protein-coupled from non-G protein-coupled pathways |
| MAPK1 | Encodes ERK2, a kinase often activated downstream of beta-arrestin | Readout for G protein-independent signaling |
| MAPK3 | Encodes ERK1, a kinase often activated downstream of beta-arrestin | Readout for G protein-independent signaling |
| SRC | Encodes SRC kinase, a signaling node downstream of many receptors | Potential effector in non-G protein-coupled neurotensin signaling |
| AKT1 | Encodes AKT1, a survival kinase | May be involved in neuroprotective effects of NTS2 and NTS3 |
| PTK2 | Encodes focal adhesion kinase, a signaling protein | Candidate downstream node in non-G protein-coupled pathways |
| EGFR | Encodes epidermal growth factor receptor, a receptor tyrosine kinase | Can crosstalk with neurotensin receptor signaling |
| TNF | Encodes tumor necrosis factor, an inflammatory cytokine | Inflammation-related readout in neurotensin biology |
| IL6 | Encodes interleukin 6, an inflammatory cytokine | Inflammation-related readout in neurotensin biology |
| CCND1 | Encodes cyclin D1, a cell cycle regulator | Proliferation readout in cancer-related neurotensin studies |
| BCL2 | Encodes BCL2, an anti-apoptotic protein | Survival readout in neuroprotection studies |
How Is neurotensin receptor activity, non-G protein-coupled Regulated?
Regulation of neurotensin receptor activity, non-G protein-coupled, can occur through receptor heterodimerization and interacting proteins. For example, heterodimerization of the kappa opioid receptor with neurotensin receptor 1 shifts signaling toward a beta-arrestin-2-biased pathway, which is a G protein-independent mechanism. The functional roles of NTS2 and NTS3 receptors also indicate that their activities are regulated in the context of the nervous system and can influence pain and neuroprotection. However, specific transcriptional or post-translational regulators of GO:0030379 are not fully defined in the provided literature, so further studies are needed to identify the full regulatory network.
neurotensin receptor activity, non-G protein-coupled and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NTSR2 | Pain and neuroprotection | NTSR2 knockout mouse or knockout cell line |
| SORT1 | Neuroprotection and cancer | SORT1 knockout cell line or knock-in reporter |
| NTSR1 | Biased signaling in pain and addiction | NTSR1 knockout with beta-arrestin-2 readout |
| OPRK1 | Opioid receptor crosstalk | OPRK1 and NTSR1 double knockout or heterodimerization model |
| ARRB2 | G protein-independent signaling | ARRB2 knockout cell line for beta-arrestin-2 assays |
Neurotensin receptors in pain and neuroprotection
NTS2 and NTS3/sortilin have functional roles in the nervous system, including pain modulation and neuroprotection, which are linked to non-G protein-coupled neurotensin receptor activity. These roles make GO:0030379 relevant to neurological and psychiatric research, and to the development of analgesics or neuroprotective agents.
Neurotensin receptors in cancer
Neurotensin receptors, including NTS2 and NTS3/sortilin, have functional roles that extend to cancer biology. Non-G protein-coupled signaling may contribute to tumor cell proliferation or survival, although the exact mechanisms require further study.
Biased signaling and opioid receptor crosstalk
The heterodimerization of the kappa opioid receptor with neurotensin receptor 1 produces a beta-arrestin-2-biased pathway, which is a G protein-independent mechanism. This crosstalk is relevant to pain and addiction research, and it highlights how GO:0030379 can influence disease-related signaling.
From neurotensin receptor activity, non-G protein-coupled-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NTSR2 mediate non-G protein-coupled neurotensin signaling? | NTSR2 knockout cell line |
| Does SORT1/NTS3 contribute to neuroprotection? | SORT1 knockout or overexpression cell model |
| Does NTSR1 heterodimerize with OPRK1 to signal via beta-arrestin-2? | NTSR1-OPRK1 double knock-in or tagged knock-in |
| Is beta-arrestin-2 required for the biased pathway? | ARRB2 knockout cell line |
| Can a point mutation in NTSR1 abolish G protein coupling while preserving beta-arrestin recruitment? | NTSR1 point-mutation knock-in |
| Does overexpression of NTSR2 change pain-related signaling? | NTSR2 overexpression cell model |
How to Study the neurotensin receptor activity, non-G protein-coupled Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Beta-arrestin recruitment assay | Recruitment of beta-arrestin-2 to the receptor | Detecting G protein-independent signaling |
| Knockout cell line | Loss of receptor or transducer function | Assigning causality to NTSR2, SORT1, NTSR1, OPRK1, or ARRB2 |
| Radioligand binding | Neurotensin binding affinity and receptor density | Confirming ligand-receptor interaction |
| ERK phosphorylation assay | Activation of MAPK pathway | Readout of beta-arrestin-dependent signaling |
| RNA sequencing | Changes in gene expression | Identifying downstream transcriptional responses |
| Proteomics | Protein-protein interactions and abundance | Discovering novel effectors of non-G protein-coupled signaling |
| Immunofluorescence | Subcellular localization of receptors | Studying receptor trafficking and internalization |
| BRET or FRET | Real-time protein-protein interactions | Monitoring receptor heterodimerization and beta-arrestin recruitment |
Beta-arrestin recruitment assays
Beta-arrestin recruitment is a key readout for G protein-independent signaling, and it is directly relevant to GO:0030379 because the kappa opioid receptor and neurotensin receptor 1 heterodimer signals through beta-arrestin-2. These assays can be performed with luciferase complementation, BRET, or GFP-based recruitment in live cells.
Knockout and knockdown approaches
Knockout or knockdown of NTSR2, SORT1, NTSR1, OPRK1, or ARRB2 can help assign specific functions to non-G protein-coupled neurotensin receptor activity. These models are essential to distinguish the contributions of individual receptors and transducers.
Ligand binding and signaling assays
Radioligand binding or fluorescent neurotensin binding assays can confirm the ligand-receptor interaction that initiates GO:0030379. Downstream signaling can be measured by ERK phosphorylation or other kinase readouts that are often used to detect beta-arrestin-dependent pathways.
Gene expression and proteomics
RNA sequencing and proteomics can identify changes in gene expression or protein interactions after neurotensin stimulation in cells expressing non-G protein-coupled receptors. These methods can reveal downstream effectors and potential disease-related pathways.
How CRISPR Can Be Used to Study GO:0030379 neurotensin receptor activity, non-G protein-coupled
Knockout
CRISPR knockout of NTSR2, SORT1, NTSR1, OPRK1, or ARRB2 can eliminate specific components of non-G protein-coupled neurotensin signaling. These knockout models are useful to test whether a given receptor or transducer is required for GO:0030379-related phenotypes.
Point Mutation
Point mutations can be introduced into NTSR1 or other receptors to disrupt G protein coupling while preserving beta-arrestin recruitment, allowing precise dissection of GO:0030379. Such models help distinguish G protein-dependent from G protein-independent functions.
Knock-in
Knock-in of tagged receptors, such as NTSR1 or OPRK1 with a fluorescent or affinity tag, enables visualization and purification of receptor complexes involved in non-G protein-coupled signaling. Tagged knock-in models are valuable for studying heterodimerization and trafficking.
Overexpression
Overexpression of NTSR2, SORT1, or NTSR1 can amplify non-G protein-coupled signaling and make downstream responses easier to measure. Overexpression models are also useful for screening compounds that target GO:0030379.
How EDITGENE Supports neurotensin receptor activity, non-G protein-coupled Research
Researchers studying neurotensin receptor activity, non-G protein-coupled-related genes often need to determine whether a candidate gene is causally involved in ligand binding, signal transmission, or downstream cellular responses. EDITGENE provides CRISPR-based cell models and screening services to help answer these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for neurotensin receptor activity, non-G protein-coupled research.
Frequently Asked Questions About neurotensin receptor activity, non-G protein-coupled
What is GO:0030379?
GO:0030379 is the Gene Ontology molecular function term for neurotensin receptor activity, non-G protein-coupled, which means binding neurotensin and transmitting a signal across the membrane without coupling to G proteins.
What is neurotensin receptor activity, non-G protein-coupled?
It is a receptor activity that binds the neuropeptide neurotensin and signals independently of G proteins, as defined by GO:0030379.
What genes are involved in neurotensin receptor activity, non-G protein-coupled?
Genes include NTS, NTSR1, NTSR2, SORT1, OPRK1, and ARRB2, based on published studies of neurotensin receptors and beta-arrestin-2-biased signaling.
Which receptors mediate non-G protein-coupled neurotensin signaling?
NTS2 and NTS3/sortilin are associated with non-G protein-coupled neurotensin activity, and neurotensin receptor 1 can participate in beta-arrestin-2-biased pathways.
How is GO:0030379 different from G protein-coupled neurotensin receptor activity?
GO:0030379 explicitly excludes coupling to G proteins, so it covers signaling through beta-arrestin or other non-G protein transducers.
What diseases are linked to neurotensin receptor activity, non-G protein-coupled?
Neurotensin receptors have roles in pain, neuroprotection, and cancer, and biased signaling at neurotensin receptor 1 is relevant to pain and addiction research.
How can I study GO:0030379 in the lab?
You can use beta-arrestin recruitment assays, knockout cell lines, radioligand binding, and RNA sequencing to study this activity.
What CRISPR models are useful for studying GO:0030379?
Knockout, point-mutation, knock-in, and overexpression models for NTSR2, SORT1, NTSR1, OPRK1, and ARRB2 are useful for dissecting this activity.
Does neurotensin receptor 1 signal through beta-arrestin-2?
Yes, heterodimerization of the kappa opioid receptor with neurotensin receptor 1 contributes to a beta-arrestin-2-biased pathway, which is G protein-independent.
Why is GO:0030379 important for drug discovery?
It defines a non-G protein-coupled signaling mode that can be targeted selectively, which may lead to drugs with fewer side effects than those targeting G protein pathways.
Conclusion
GO:0030379, neurotensin receptor activity, non-G protein-coupled, is a precise molecular function term for neurotensin receptors that signal without G proteins. It is supported by studies of NTS2, NTS3/sortilin, and the kappa opioid receptor-neurotensin receptor 1 heterodimer, which signals through beta-arrestin-2. Understanding this term helps researchers design better experiments and interpret disease-related signaling in pain, neuroprotection, and cancer.
References
- 1. Mazella J et al.. 2006. Functional roles of the NTS2 and NTS3 receptors.. Peptides 27(10):2469-75 PMID: 16872720
- 2. Liu H et al.. 2016. Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2-biased pathway.. Biochim Biophys Acta 1863(11):2719-2738 PMID: 27523794
